Clinical Characteristics of Cerebral Venous Sinus Thrombosis in Patients with Systemic Lupus Erythematosus: A Single-Centre Experience in China

Table 2

Clinical manifestations of SLE patients with CVST.

Number	Gender/age (y)	Organ involvement	SLEDAI	Site of; CVST occlusion	Treatment	Outcome
1	F/16	F, K, H	21	SSS, (B) TS, (B) SS	GC (pulse) + CTX	Lost
2	F/18	F, K, H, C	25	(L) TS	GC (pulse) + CTX	Died
3	F/17	F, R, A, K	22	(R) TS, (R) SS	GC + CTX	Died
4	F/20	F, H	15	SSS	GC (pulse) + CTX	Survived
5	M/38	H, K	20	SSS, (B) TS, (B) SS	GC (pulse) + CTX + FK506	Survived
6	F/36	R, A, H, C, P	17	(L) TS, (L) SS	GC + CTX	Survived
7	F/43	R, A, S	18	SSS, (L) TS	GC + CTX	Survived
8	F/52	A, K, S	19	(R) ISS, (L) TS	GC (pulse) + CTX	Survived
9	F/30	F, K, P	24	(R) SS, (R) TS	GC (pulse) + CTX	Survived
10	F/20	S, K, H, TTP	30	SSS, (L) TS	GC (pulse) + CTX + MMF + plasmapheresis	Survived
11	M/30	None	16	SSS, (B) TS	GC (pulse) + CTX	Survived
12	M/14	F, GI, K	20	(R) SS	GC (pulse) + CTX	Survived
13	F/41	R, A, K	18	(B) TS, (B) SS	GC (pulse) + CTX	Died
14	M/28	K, A	20	(L) SS, (L) TS	GC (pulse) + CTX	Survived
15	F/30	R, H	17	(R) TS	GC + CTX	Survived
16	M/34	K	20	(L) SS	GC (pulse) + CTX	Survived
17	F/15	K, CAPS	19	SSS	GC (pulse) + CTX	Survived

Organ Involvement. F: fever, R: rash, H: hemocytopenia, C: cardiac involvement, K: kidney disease, A: arthritis, P: pulmonary involvement, S: serositis, GI: gastrointestinal involvement, and CAPS: catastrophic antiphospholipid syndrome.
Site of CVST Occlusion. B: bilateral, L: left, R: right, SSS: superior sagittal sinus, ISS: inferior sagittal sinus, SS: sigmoid sinus, and TS: transverse sinus.
Treatment. GC: glucocorticoid, CTX: cyclophosphamide, and MMF: mycophenolate mofetil.